C22orf9_5031439G07Rik Activators
KIAA0930 is a designation for a protein encoded by the KIAA0930 gene. The KIAA series represents a collection of genes initially identified in a large-scale cDNA sequencing project from human adult and fetal brains, with the aim of cataloging novel genes. KIAA0930 is one of these genes, and while its specific function is not fully characterized, the protein encoded by this gene is thought to participate in important cellular processes.
Based on its sequence homology and predicted domains, KIAA0930 may be involved in intracellular signaling pathways, protein-protein interactions, and possibly in the regulation of gene expression. Proteins that are identified through such large-scale sequencing projects often require further experimental validation to determine their exact role within the cell.The KIAA0930 protein may localize to specific subcellular compartments where it interacts with other proteins or cellular structures, contributing to complex molecular pathways. Its function could be versatile, ranging from a structural role within the cytoskeleton, to a more dynamic part in signal transduction or the transport of molecules within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor may result in the demethylation of gene promoters, potentially increasing the expression of "KIAA0930". | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, Trichostatin A can alter chromatin structure, potentially enhancing the transcription of "KIAA0930". | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts on nuclear receptors and can modulate gene expression, possibly upregulating "KIAA0930". | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which could lead to signaling cascades affecting "KIAA0930" activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that activates PKA, which could influence signaling pathways involving "KIAA0930". | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits certain kinases, which might shift signaling balances and enhance pathways that "KIAA0930" is part of. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which could affect downstream signaling pathways and potentially increase "KIAA0930" activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin may alter cellular growth pathways, potentially affecting "KIAA0930" expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This inhibitor of p38 MAPK could modulate stress-related signaling pathways and indirectly affect "KIAA0930" activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, potentially altering signaling pathways that include "KIAA0930". | ||||||